{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "San Juan",
      "state": "PR",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77433",
      "recalling_firm": "Lantheus MI Radipharmaceuticals Inc.",
      "address_1": "150 Calle Federico Costa Ste 1",
      "address_2": "N/A",
      "postal_code": "00918-1339",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Puerto Rico",
      "recall_number": "D-0942-2017",
      "product_description": "Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01",
      "product_quantity": "26 doses",
      "reason_for_recall": "Failed Impurities/Degradation   Specifications; out of specification result for Acetonitrile residual solvent",
      "recall_initiation_date": "20170518",
      "center_classification_date": "20170705",
      "termination_date": "20171206",
      "report_date": "20170712",
      "code_info": "Lot: FDG170518-01, exp 5/18/2017"
    }
  ]
}